Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Golimumab

Golimumab

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Golimumab

26 trials tracked of Golimumab: 21 in phase 3 or 4 and 1 with published results. The most-cited published study has 10 citations.

26Trials tracked
21Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 7 Phase 3 14 Phase 2 3 Other / NA 2
  1. Phase 4 Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038) Completed · 10 cited
  2. Phase 4 A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis Completed
  3. Phase 4 Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) Completed
  4. Phase 4 Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022). Completed
  5. Phase 4 The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) Completed
  6. Phase 4 Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Completed
Show 20 more trials
  1. Phase 4 A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) Completed
  2. Phase 3 Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation Completed
  3. Phase 3 GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA Completed
  4. Phase 3 Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients Completed
  5. Phase 3 Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis Completed
  6. Phase 3 A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis Completed
  7. Phase 3 Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) Completed
  8. Phase 3 A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy Completed
  9. Phase 3 A Study of Golimumab in Participants With Active Psoriatic Arthritis Completed
  10. Phase 3 A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis. Completed
  11. Phase 3 A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy Completed
  12. Phase 3 A Study of Golimumab in Participants With Active Ankylosing Spondylitis Completed
  13. Phase 3 Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy Completed
  14. Phase 3 A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis Completed
  15. Phase 3 An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy Completed
  16. Phase 2 A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis Completed
  17. Phase 2 A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes Completed
  18. Phase 2 An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis Completed
  19. N/A Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis Failing Adalimumab Completed
  20. N/A Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis Completed

Showing the 26 most-cited and recently-updated of 26 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.